BioMarin Announces Record Revenues in Second Quarter 2022; Increases Full-year 2022 Top and Bottom-line Guidance

Go back to BioMarin Announces Record Revenues in Second Quarter 2022; Increases Full-year 2022 Top and Bottom-line Guidance
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 59.29 -0.68 (1.13%)
Previous Close $59.97    52 Week High $108.96 
Open $60.15    52 Week Low $62.12 
Day High $60.28    P/E N/A 
Day Low $58.44    EPS $-1.27 
Volume 336,370